Akero Therapeutics Inc (AKRO)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart
Ticker: AKRO Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-16 2025-04-15 PS Planned sale

Yale Catriona

Chief Development Officer

Officer
1,000 -1.2%
38.62
USD 46,339 		1,000 -1.2% 38.62 USD 100,000
2025-04-16 2025-04-15 PS Planned sale

Yale Catriona

Chief Development Officer

Officer
1,000 -7.6%
37.80
USD 297,623 		1,000 -7.6% 37.80 USD 100,000
2025-04-11 2025-04-10 PS Planned sale

Cheng Andrew

President and CEO

Executive Director
1,000 -4.6%
35.23
USD 1,056,780 		1,000 -4.6% 35.23 USD 100,000
2025-04-10 2025-04-07 PS Planned sale

Rolph Timothy

Chief Scientific Officer

Officer
1,000 -0.1%
37.92
USD 7,583 		1,000 -0.1% 37.92 USD 100,000
2025-04-10 2025-04-07 PS Planned sale

Rolph Timothy

Chief Scientific Officer

Officer
1,000 -0.1%
36.93
USD 3,693 		1,000 -0.1% 36.93 USD 100,000
2025-04-10 2025-04-07 PS Planned sale

Rolph Timothy

Chief Scientific Officer

Officer
1,000 -2.2%
36.05
USD 135,203 		1,000 -2.2% 36.05 USD 100,000
2025-04-10 2025-04-07 PS Planned sale

Rolph Timothy

Chief Scientific Officer

Officer
1,000 -1.3%
35.36
USD 77,783 		1,000 -1.3% 35.36 USD 100,000
2025-03-27 2025-03-27 B Purchase

Graham G. Walmsley

Non-Executive Director
50,000 +4.3%
43.55
USD 2,177,700 		50,000 +4.3% 43.55 USD 2,177,700
2025-03-27 2025-03-26 B Purchase

Graham G. Walmsley

Non-Executive Director
58,691 +5.4%
43.01
USD 2,524,417 		58,691 +5.4% 43.01 USD 2,524,417
2025-03-27 2025-03-25 B Purchase

Graham G. Walmsley

Non-Executive Director
91,309 +9.1%
44.75
USD 4,085,804 		91,309 +9.1% 44.75 USD 4,085,804
2025-03-18 2025-03-17 PS Planned sale

Yale Catriona

Chief Development Officer

Officer
1,799 -1.9%
45.05
USD 81,045 		1,799 -1.9% 45.05 USD 81,045
2025-03-18 2025-03-17 PS Planned sale

Yale Catriona

Chief Development Officer

Officer
8,201 -7.8%
44.70
USD 366,560 		8,201 -7.8% 44.70 USD 366,560
2025-03-14 2025-03-12 S Sale

Cheng Andrew

President and CEO

Executive Director
1,738 -0.3%
44.88
USD 78,001 		1,738 -0.3% 44.88 USD 78,001
2025-03-14 2025-03-12 S Sale

Young Jonathan

Chief Operating Officer

Officer
607 -0.3%
44.88
USD 27,242 		607 -0.3% 44.88 USD 27,242
2025-03-14 2025-03-12 S Sale

Yale Catriona

Chief Development Officer

Officer
614 -0.6%
44.88
USD 27,556 		614 -0.6% 44.88 USD 27,556
2025-03-14 2025-03-12 S Sale

White William Richard

Chief Financial Officer

Officer
676 -1.1%
44.88
USD 30,339 		676 -1.1% 44.88 USD 30,339
2025-03-14 2025-03-12 S Sale

Rolph Timothy

Chief Scientific Officer

Officer
516 -0.3%
44.88
USD 23,158 		516 -0.3% 44.88 USD 23,158
2025-03-12 2025-03-10 PS Planned sale

Cheng Andrew

President and CEO

Executive Director
1,216 -0.2%
42.31
USD 51,453 		1,216 -0.2% 42.31 USD 51,453
2025-03-12 2025-03-10 PS Planned sale

Cheng Andrew

President and CEO

Executive Director
28,784 -4.2%
41.75
USD 1,201,617 		28,784 -4.2% 41.75 USD 1,201,617
2025-03-07 2025-03-05 PS Planned sale

Rolph Timothy

Chief Scientific Officer

Officer
3,162 -1.8%
44.90
USD 141,974 		3,162 -1.8% 44.90 USD 141,974
2025-03-07 2025-03-05 PS Planned sale

Rolph Timothy

Chief Scientific Officer

Officer
9,338 -5.1%
44.40
USD 414,617 		9,338 -5.1% 44.40 USD 414,617
2025-03-05 2025-03-04 PS Planned sale

Young Jonathan

Chief Operating Officer

Officer
38,553 -16.1%
45.07
USD 1,737,622 		38,553 -16.1% 45.07 USD 1,737,622
2025-03-05 2025-03-04 PS Planned sale

Young Jonathan

Chief Operating Officer

Officer
11,447 -4.6%
44.17
USD 505,591 		11,447 -4.6% 44.17 USD 505,591
2025-03-05 2025-03-03 PS Planned sale

Lamy Patrick

Senior VP, Commercial Strategy

Officer
1,000 -2.9%
48.09
USD 48,090 		1,000 -2.9% 48.09 USD 48,090
2025-02-21 2025-02-18 PS Planned sale

Yale Catriona

Chief Development Officer

Officer
900 -0.9%
50.63
USD 45,571 		900 -0.9% 50.63 USD 45,571
2025-02-21 2025-02-18 PS Planned sale

Yale Catriona

Chief Development Officer

Officer
9,100 -8.6%
49.79
USD 453,089 		9,100 -8.6% 49.79 USD 453,089
2025-02-11 2025-02-10 PS Planned sale

Cheng Andrew

President and CEO

Executive Director
200 -0.0%
55.81
USD 11,162 		200 -0.0% 55.81 USD 11,162
2025-02-11 2025-02-10 PS Planned sale

Cheng Andrew

President and CEO

Executive Director
749 -0.1%
54.55
USD 40,855 		749 -0.1% 54.55 USD 40,855
2025-02-11 2025-02-10 PS Planned sale

Cheng Andrew

President and CEO

Executive Director
9,972 -1.4%
53.67
USD 535,157 		9,972 -1.4% 53.67 USD 535,157
2025-02-11 2025-02-10 PS Planned sale

Cheng Andrew

President and CEO

Executive Director
6,439 -0.9%
52.91
USD 340,675 		6,439 -0.9% 52.91 USD 340,675
2025-02-11 2025-02-10 PS Planned sale

Cheng Andrew

President and CEO

Executive Director
12,640 -1.8%
51.75
USD 654,145 		12,640 -1.8% 51.75 USD 654,145
2025-02-07 2025-02-05 PS Planned sale

Rolph Timothy

Chief Scientific Officer

Officer
5,903 -3.4%
56.92
USD 336,022 		5,903 -3.4% 56.92 USD 336,022
2025-02-07 2025-02-05 PS Planned sale

Rolph Timothy

Chief Scientific Officer

Officer
12,847 -6.8%
56.33
USD 723,607 		12,847 -6.8% 56.33 USD 723,607
2025-02-05 2025-02-03 PS Planned sale

Young Jonathan

Chief Operating Officer

Officer
4,900 -1.9%
54.06
USD 264,879 		4,900 -1.9% 54.06 USD 264,879
2025-02-05 2025-02-03 PS Planned sale

Young Jonathan

Chief Operating Officer

Officer
5,100 -2.0%
53.57
USD 273,182 		5,100 -2.0% 53.57 USD 273,182
2025-02-07 2025-01-30 B Purchase

Graham G. Walmsley

Non-Executive Director
200,000 +25.0%
48.00
USD 9,600,000 		200,000 +25.0% 48.00 USD 9,600,000
2025-01-31 2025-01-27 PS Planned sale

Yale Catriona

Chief Development Officer

Officer
27,340 -22.2%
57.02
USD 1,559,036 		27,340 -22.2% 57.02 USD 1,559,036
2025-01-31 2025-01-27 PS Planned sale

Yale Catriona

Chief Development Officer

Officer
9,250 -7.0%
55.95
USD 517,528 		9,250 -7.0% 55.95 USD 517,528
2025-01-31 2025-01-27 PS Planned sale

Yale Catriona

Chief Development Officer

Officer
17,000 -11.4%
55.16
USD 937,652 		17,000 -11.4% 55.16 USD 937,652
2025-01-31 2025-01-27 PS Planned sale

Yale Catriona

Chief Development Officer

Officer
8,700 -8.3%
57.01
USD 495,961 		8,700 -8.3% 57.01 USD 495,961
2025-01-31 2025-01-27 PS Planned sale

Yale Catriona

Chief Development Officer

Officer
14,467 -12.2%
55.95
USD 809,429 		14,467 -12.2% 55.95 USD 809,429
2025-01-31 2025-01-27 PS Planned sale

Yale Catriona

Chief Development Officer

Officer
25,907 -17.9%
55.15
USD 1,428,823 		25,907 -17.9% 55.15 USD 1,428,823
2025-01-29 2025-01-27 PS Planned sale

Cheng Andrew

President and CEO

Executive Director
3,377 -0.5%
56.89
USD 192,118 		3,377 -0.5% 56.89 USD 192,118
2025-01-29 2025-01-27 PS Planned sale

Cheng Andrew

President and CEO

Executive Director
2,381 -0.3%
55.53
USD 132,217 		2,381 -0.3% 55.53 USD 132,217
2025-01-29 2025-01-27 PS Planned sale

Cheng Andrew

President and CEO

Executive Director
24,242 -3.2%
54.56
USD 1,322,644 		24,242 -3.2% 54.56 USD 1,322,644
2025-01-29 2025-01-27 PS Planned sale

Rolph Timothy

Chief Scientific Officer

Officer
12,379 -6.8%
56.97
USD 705,232 		12,379 -6.8% 56.97 USD 705,232
2025-01-29 2025-01-27 PS Planned sale

Rolph Timothy

Chief Scientific Officer

Officer
5,059 -2.7%
55.62
USD 281,382 		5,059 -2.7% 55.62 USD 281,382
2025-01-29 2025-01-27 PS Planned sale

Rolph Timothy

Chief Scientific Officer

Officer
13,812 -6.9%
54.76
USD 756,345 		13,812 -6.9% 54.76 USD 756,345
2025-01-29 2025-01-27 PS Planned sale

Lamy Patrick

Senior VP, Commercial Strategy

Officer
5,000 -13.0%
57.03
USD 285,150 		5,000 -13.0% 57.03 USD 285,150
2025-01-06 2025-01-02 PS Planned sale

Young Jonathan

Chief Operating Officer

Officer
10,000 -4.4%
28.03
USD 280,330 		10,000 -4.4% 28.03 USD 280,330
2024-12-18 2024-12-17 PS Planned sale

Rolph Timothy

Chief Scientific Officer

Officer
3,800 -2.1%
31.10
USD 118,172 		3,800 -2.1% 31.10 USD 118,172
2024-12-18 2024-12-16 PS Planned sale

Yale Catriona

Chief Development Officer

Officer
9,074 -8.7%
29.11
USD 264,117 		9,074 -8.7% 29.11 USD 264,117
2024-12-18 2024-12-16 PS Planned sale

Lamy Patrick

Senior VP, Commercial Strategy

Officer
1,000 -2.8%
29.13
USD 29,130 		1,000 -2.8% 29.13 USD 29,130
2024-12-12 2024-12-10 PS Planned sale

Rolph Timothy

Chief Scientific Officer

Officer
2,450 -1.4%
31.03
USD 76,024 		2,450 -1.4% 31.03 USD 76,024
2024-12-12 2024-12-10 S Sale

Rolph Timothy

Chief Scientific Officer

Officer
2,368 -1.3%
30.79
USD 72,911 		2,368 -1.3% 30.79 USD 72,911
2024-12-12 2024-12-10 S Sale

Young Jonathan

Chief Operating Officer

Officer
2,503 -1.2%
30.79
USD 77,067 		2,503 -1.2% 30.79 USD 77,067
2024-12-12 2024-12-10 S Sale

Lamy Patrick

Senior VP, Commercial Strategy

Officer
925 -4.9%
30.79
USD 28,481 		925 -4.9% 30.79 USD 28,481
2024-12-12 2024-12-10 S Sale

Yale Catriona

Chief Development Officer

Officer
2,810 -3.8%
30.79
USD 86,520 		2,810 -3.8% 30.79 USD 86,520
2024-12-12 2024-12-10 S Sale

White William Richard

Chief Financial Officer

Officer
2,817 -6.8%
30.79
USD 86,735 		2,817 -6.8% 30.79 USD 86,735
2024-12-12 2024-12-10 S Sale

Cheng Andrew

President and CEO

Executive Director
7,855 -1.3%
30.79
USD 241,855 		7,855 -1.3% 30.79 USD 241,855
2024-12-04 2024-12-02 PS Planned sale

Young Jonathan

Chief Operating Officer

Officer
10,000 -4.6%
32.13
USD 321,310 		10,000 -4.6% 32.13 USD 321,310
2024-12-04 2024-12-02 PS Planned sale

Cheng Andrew

President and CEO

Executive Director
25,000 -4.0%
32.09
USD 802,250 		25,000 -4.0% 32.09 USD 802,250
2024-11-19 2024-11-15 PS Planned sale

Yale Catriona

Chief Development Officer

Officer
300 -0.4%
28.82
USD 8,647 		300 -0.4% 28.82 USD 8,647
2024-11-19 2024-11-15 PS Planned sale

Yale Catriona

Chief Development Officer

Officer
8,761 -10.5%
27.69
USD 242,627 		8,761 -10.5% 27.69 USD 242,627
2024-11-08 2024-11-06 PS Planned sale

Yale Catriona

Chief Development Officer

Officer
10,000 -11.9%
35.19
USD 351,890 		10,000 -11.9% 35.19 USD 351,890
2024-11-05 2024-11-01 PS Planned sale

Cheng Andrew

President and CEO

Executive Director
27,086 -4.3%
32.50
USD 880,268 		27,086 -4.3% 32.50 USD 880,268
2024-11-05 2024-11-01 PS Planned sale

Cheng Andrew

President and CEO

Executive Director
81,280 -11.8%
31.47
USD 2,558,044 		81,280 -11.8% 31.47 USD 2,558,044
2024-11-05 2024-11-01 PS Planned sale

Young Jonathan

Chief Operating Officer

Officer
292 -0.1%
32.94
USD 9,618 		292 -0.1% 32.94 USD 9,618
2024-11-05 2024-11-01 PS Planned sale

Young Jonathan

Chief Operating Officer

Officer
15,481 -6.7%
32.27
USD 499,525 		15,481 -6.7% 32.27 USD 499,525
2024-11-05 2024-11-01 PS Planned sale

Young Jonathan

Chief Operating Officer

Officer
34,943 -13.1%
31.25
USD 1,092,109 		34,943 -13.1% 31.25 USD 1,092,109
2024-11-01 2024-11-01 PS Planned sale

Yale Catriona

Chief Development Officer

Officer
15,485 -17.3%
32.62
USD 505,105 		15,485 -17.3% 32.62 USD 505,105
2024-11-01 2024-10-30 PS Planned sale

Yale Catriona

Chief Development Officer

Officer
4,515 -5.7%
32.53
USD 146,855 		4,515 -5.7% 32.53 USD 146,855
2024-10-18 2024-10-18 PS Planned sale

Cheng Andrew

President and CEO

Executive Director
226 -0.0%
32.12
USD 7,259 		226 -0.0% 32.12 USD 7,259
2024-10-18 2024-10-18 PS Planned sale

Cheng Andrew

President and CEO

Executive Director
63,313 -9.5%
31.53
USD 1,996,069 		63,313 -9.5% 31.53 USD 1,996,069
2024-10-18 2024-10-17 PS Planned sale

Cheng Andrew

President and CEO

Executive Director
3,103 -0.5%
31.12
USD 96,559 		3,103 -0.5% 31.12 USD 96,559
// ... existing code ... // ... rest of the file ...